within Pharmacolibrary.Drugs.V_Various.V08D_UltrasoundContrastMedia.V08DA03_Perflenapent;

model Perflenapent
  extends Pharmacolibrary.Drugs.ATC.V.V08DA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V08DA03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Perflenapent is a second-generation perfluorocarbon-based contrast agent developed for use in diagnostic imaging, such as computed tomography (CT) and magnetic resonance imaging (MRI), particularly for enhancing liver imaging. It functions as a blood pool agent by remaining within the vascular compartment for a prolonged period. As of 2024, perflenapent is not an approved drug in the US or EU and has not been widely used clinically.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies with detailed parameters were identified for perflenapent in humans. Values below are given as estimated based on properties of similar perfluorocarbon contrast agents in adult volunteers.</p><h4>References</h4><ol><li><p>Grayburn, P (1997). Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography. <i>Clinical cardiology</i> 20(10 Suppl 1) I12–I18. DOI:<a href=\"https://doi.org/10.1002/clc.4960201305\">10.1002/clc.4960201305</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9383597/\">https://pubmed.ncbi.nlm.nih.gov/9383597</a></p></li><li><p>Correas, JM, et al., &amp; Hélénon, O (2001). Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. <i>European radiology</i> 11(8) 1316–1328. DOI:<a href=\"https://doi.org/10.1007/s003300100940\">10.1007/s003300100940</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11519538/\">https://pubmed.ncbi.nlm.nih.gov/11519538</a></p></li><li><p>Wang, J, et al., &amp; Kummel, AC (2018). Extended Lifetime In Vivo Pulse Stimulated Ultrasound Imaging. <i>IEEE transactions on medical imaging</i> 37(1) 222–229. DOI:<a href=\"https://doi.org/10.1109/TMI.2017.2740784\">10.1109/TMI.2017.2740784</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28829305/\">https://pubmed.ncbi.nlm.nih.gov/28829305</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Perflenapent;
